Development, Characterization, and Optimization of a Novel Abiraterone Acetate Formulation to Improve Biopharmaceutical Attributes Aided by Pharmacokinetic Modelling
Crossref DOI link: https://doi.org/10.1208/s12249-021-02168-7
Published Online: 2021-11-22
Published Print: 2022-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dahiya, Sandeep
Savjani, Ketan
Savjani, Jignasa
Text and Data Mining valid from 2021-11-22
Version of Record valid from 2021-11-22
Article History
Received: 21 June 2021
Accepted: 20 October 2021
First Online: 22 November 2021
Declarations
:
: The authors declare no competing interests.